Our core
We exist for our users, and we only have the right to exist if we create real value for our customers and users.
With us, you can really make a difference
We are today a small company with high ambitions at the beginning of our commercial journey. With roots from KTH and KI, we have a strong scientific foundation in everything we do, both in the medical and technical fields, and we collaborate with research teams to ensure that we always validate the benefit of what we do.
Evira has been used in clinical practice since 2018
Every day, patients and clinical staff use Evira in the treatment of childhood obesity.
4 500+
patients
Thousands of patients have received or are receiving help to treat their obesity with Evira today
1.5 years
average time in treatment
This indicates the median and average duration of treatment with Evira, varying based on factors such as the initial degree of obesity.
1 000 000+
measurements
Half a million measurements have been carried out in the safety of the patients' own homes
−0.3
BMI-SDS
This is how much, on average, a patient reduces their BMI-SDS (measure of relative degree of overweight) after one year of treatment with Evira
7 000+
treatment years
Patients already contribute thousands of treatment years that we regularly analyze to make the tool and treatment better
50
clinics
This is how many clinics have used Evira for pediatric childhood obesity treatment i
five different countries
Evira is being used here today
This map shows which clinics that use Evira to treat childhood obesity. Contact the clinic closest to you if you want to know more about what it means to use Evira to treat your child's obesity.
